Stock Scorecard
Stock Summary for Humana Inc (HUM) - $257.68 as of 10/3/2025 4:09:39 PM EST
Total Score
12 out of 30
Safety Score
60 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HUM
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HUM
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HUM
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HUM
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HUM (60 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 10 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HUM
Financial Details for HUM
Company Overview |
|
|---|---|
| Ticker | HUM |
| Company Name | Humana Inc |
| Country | USA |
| Description | Humana Inc. (HUM) is a leading American health insurance provider headquartered in Louisville, Kentucky, specializing in an array of health and wellness solutions. The company offers a diverse range of Medicare Advantage plans, individual and family health insurance, and specialty products, aimed at enhancing the quality of care and promoting healthier lifestyles among its members. With a strong commitment to innovation and customer-centric services, Humana leverages advanced analytics and technology to improve healthcare delivery and outcomes, positioning itself as a key player in the evolving healthcare landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | HEALTHCARE PLANS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/5/2025 |
Stock Price History |
|
| Last Day Price | 257.68 |
| Price 4 Years Ago | 447.57 |
| Last Day Price Updated | 10/3/2025 4:09:39 PM EST |
| Last Day Volume | 4,466,952 |
| Average Daily Volume | 1,847,451 |
| 52-Week High | 314.25 |
| 52-Week Low | 206.15 |
| Last Price to 52 Week Low | 25.00% |
Valuation Measures |
|
| Trailing PE | 21.72 |
| Industry PE | 18.42 |
| Sector PE | 41.81 |
| 5-Year Average PE | 17.75 |
| Free Cash Flow Ratio | 7.67 |
| Industry Free Cash Flow Ratio | 9.05 |
| Sector Free Cash Flow Ratio | 30.43 |
| Current Ratio Most Recent Quarter | 1.95 |
| Total Cash Per Share | 33.59 |
| Book Value Per Share Most Recent Quarter | 151.61 |
| Price to Book Ratio | 1.69 |
| Industry Price to Book Ratio | 2.09 |
| Sector Price to Book Ratio | 32.30 |
| Price to Sales Ratio Twelve Trailing Months | 0.28 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.49 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.26 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 120,272,000 |
| Market Capitalization | 30,991,688,960 |
| Institutional Ownership | 96.01% |
Dividends |
|
| Ex-Dividend Date | 9/26/2025 |
| Previous Dividend Amount | 0.8850 |
| Current Dividend Amount | 0.8850 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 3.54 |
| Trailing Annual Dividend Yield | 1.37% |
| Forward Annual Dividend Rate | 3.54 |
| Forward Annual Dividend Yield | 1.37% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 1.41% |
| 5-Year Average Dividend Yield | 0.86% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 6.04% |
| All-Time Dividend Growth Rate Percentage | 8.30% |
| Dividend Payout Ratio | 27.11% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -19.80% |
| Annual Earnings Growth | -51.51% |
| Reported EPS 12 Trailing Months | 13.06 |
| Reported EPS Past Year | 17.85 |
| Reported EPS Prior Year | 16.19 |
| Net Income Twelve Trailing Months | 1,576,000,000 |
| Net Income Past Year | 1,207,000,000 |
| Net Income Prior Year | 2,489,000,000 |
| Quarterly Revenue Growth YOY | 9.60% |
| 5-Year Revenue Growth | 12.66% |
| Operating Margin Twelve Trailing Months | 3.58% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 4,040,000,000 |
| Total Cash Past Year | 2,221,000,000 |
| Total Cash Prior Year | 4,694,000,000 |
| Net Cash Position Most Recent Quarter | -8,546,000,000 |
| Net Cash Position Past Year | -8,923,000,000 |
| Long Term Debt Past Year | 11,144,000,000 |
| Long Term Debt Prior Year | 10,213,000,000 |
| Total Debt Most Recent Quarter | 12,586,000,000 |
| Equity to Debt Ratio Past Year | 0.60 |
| Equity to Debt Ratio Most Recent Quarter | 0.59 |
| Total Stockholder Equity Past Year | 16,375,000,000 |
| Total Stockholder Equity Prior Year | 16,262,000,000 |
| Total Stockholder Equity Most Recent Quarter | 18,234,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 2,439,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 20.28 |
| Free Cash Flow Past Year | 2,391,000,000 |
| Free Cash Flow Prior Year | 2,977,000,000 |
Options |
|
| Put/Call Ratio | 0.45 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.42 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/4/2025 1:32:13 AM EST |